Melinda Rezeli
Papers
1
Total Citations
32
H-Index
1
About
Melinda Rezeli is a leading figure in biobanking and clinical proteomics, whose work has fundamentally advanced the standardization and scalability of blood sample processing for large-scale biomedical research. Her most-cited paper, "Large scale biobanking of blood — The importance of high density sample processing procedures" (2012), with 32 citations, established critical protocols for high-throughput, reproducible handling of biospecimens—a cornerstone for modern biobanks. Rezeli’s major contributions lie in optimizing pre-analytical workflows, ensuring that millions of blood samples collected in population studies maintain integrity for downstream proteomic and genomic analyses. This work directly impacts the reliability of biomarker discovery and translational medicine. Beyond this landmark study, her research integrates mass spectrometry-based proteomics with biobank infrastructure, enabling large-scale, high-quality data generation. Rezeli’s achievements include co-developing automated sample processing pipelines that have been adopted by major biobanks, and her insights have shaped international guidelines for biospecimen quality. For students and researchers, her career exemplifies how rigorous methodological innovation in biobanking underpins the reproducibility and success of large-scale health studies, making her a pivotal figure in the transition from bench to population-level science.
Research Focus
Key Achievements
Top Papers
- 1